Merck & Co., Inc. (MRK)
TSX
Closed
Oct 9, 2026
Day's Range
31.7752 wk Range
18.68Overview - MRK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
544.43B
P/E (Trailing)
‪118.14‬
PEG Ratio
‪-0.90‬
Price / Sales (TTM)
‪7.83‬
Price / Book
‪12.03‬
EV / EBITDA
‪18.70‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪74.80%‬
Operating Margin
‪34.49%‬
Return on Assets
‪13.33%‬
Return on Equity
‪34.66%‬
Ownership
Shares Outstanding
2.46B
Price stats
50-Day Avg
‪31.20‬
200-Day Avg
‪27.68‬
Dividends
Frequency
Quarterly
Market Cap - MRK - Merck & Co., Inc.
Peers - MRK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
- MRKTSXMerck & Co., Inc.509.66BMarket Cap+46.01%52-week change118.14P/E (Trailing)‪74.80%‬Profit Margin
- LLYTSXEli Lilly CDR1.45TMarket Cap+37.24%52-week change37.05P/E (Trailing)‪83.04%‬Profit Margin
- ABBVTSXAbbVie Inc. CDR640.88BMarket Cap+13.80%52-week change69.30P/E (Trailing)‪70.23%‬Profit Margin
- JNJTSXJohnson & Johnson630.04BMarket Cap+26.98%52-week change30.25P/E (Trailing)‪21.48%‬Profit Margin
- ROGTSXRoche Holding AG American Depositary Receipt524.02BMarket Cap+20.55%52-week change22.31P/E (Trailing)‪73.72%‬Profit Margin
- AMGNTSXAmgen Inc. Canadian Depositary Receipt304.51BMarket Cap+18.18%52-week change24.46P/E (Trailing)‪67.24%‬Profit Margin
- GILDTSXGilead Sciences Inc. Canadian Depositary Receipt243.85BMarket Cap+15.67%52-week change17.00P/E (Trailing)‪78.82%‬Profit Margin
Profile Summary - MRK - Merck & Co., Inc.
About
Merck & Co., Inc. is a leading global healthcare company specializing in the discovery, development, manufacturing, and marketing of prescription medicines, vaccines, biologic therapies, and animal health products. Its pharmaceutical segment features blockbuster drugs like Keytruda, a leading immuno-oncology treatment…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
